Skip to main content
Clinical Trials/NCT01218087
NCT01218087TerminatedNot Applicable

Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU

Boston Children's Hospital1 site in 1 country88 target enrollmentStarted: April 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
88
Locations
1
Primary Endpoint
Cranial Abnormalities Were Measured at Hospital Discharge

Study Overview

Brief Summary

Many hospitalized infants can develop a flattening of the back or sides of their head. This condition develops gradually when an infant's head rests on a firm or semi-firm surface for a prolonged period of time. Premature infants are more likely to have a positional head shape deformity because they may spend longer periods of time in a crib. Infants participating in this study will be randomly assigned to either standard treatment, which is a moldable positioner device, or to a cranial cup device and moldable positioner for positioning. The purpose of this prospective single-blinded randomized clinical trial will be to evaluate the effectiveness of the cranial cup in preventing positional head shape deformity in the NICU patient population.

Detailed Description

The primary outcome for this study will be cranial index and cranial symmetry measured at hospital discharge; the secondary outcome measure is the incidence of oxygen desaturation events (apnea, bradycardia and oxygen desaturation).

The pilot study was undertaken to evaluate if the cranial cup can be successfully incorporated into the NICU patient care regime, the pilot study included 5 infants.

The main trial enrollment was estimated to be 160 infants from 4 centers. Upon enrollment infants will be randomized to one of two study groups

  • Cranial cup and moldable positioner
  • Moldable positioner

Inclusion criteria:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
— to 10 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •1. Infants born at \>/= 22 weeks gestation
  • •2. Infant that are \ 14 days from the time of enrollment

Exclusion Criteria

  • •Infants that require only prone positioning to maintain airway patency (such as those with Pierre Robin Syndrome/Sequence) will not be eligible to participate; this is because infants must be able to lie supine for at least part of the day to use the cranial cup
  • •Infants requiring medical devices such as a continuous ventricular drain, subgaleal shunt, or intravenous catheters (unless placement of the IV is temporary) prevent proper positioning using the cranial cup
  • •Infants with a craniofacial anomaly, cervical anomaly, or critical airway infants
  • •Infants with Cutis Aplasia or significant skin breakdown to the scalp, because the cranial cup may worsen a preexisting condition
  • •Infants with a prenatal diagnosis of craniosynostosis
  • •Infants deemed not suitable for participation by the attending neonatologist
  • •Infants that are to be transferred to a non-participating hospital within 14 days of enrollment as this timeframe may not be adequate to show a difference in head shapes

Arms & Interventions

Cranial cup device and Moldable positioner device

Experimental

The cranial cup for 12/24 hours and the moldable positioner device was used for positioning infants the remainder of the 24 hours

Intervention: Cranial cup device and Moldable positioner (Device)

Cranial cup device and Moldable positioner device

Experimental

The cranial cup for 12/24 hours and the moldable positioner device was used for positioning infants the remainder of the 24 hours

Intervention: Moldable positioner device (Device)

Moldable positioner device

Active Comparator

Moldable positioner device was used for positioning infants for 24/24 hours

Intervention: Moldable positioner device (Device)

Outcomes

Primary Outcomes

Cranial Abnormalities Were Measured at Hospital Discharge

Time Frame: up to 120 days

Cranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.

Secondary Outcomes

  • Incidence of Cardiorespiratory(daily up to 120 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michele DeGrazia

Director Nursing Research, NICU

Boston Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials